AZN

Astrazeneca plc - ADR

$51.29

+0.41 (+0.81%)

quotes and stock data delayed 15 minutes

Cash

$8.45B

Burn Rate (Qtr)

$648M

Mkt Cap

$134.7b

52 wk hi

52 wk low

37.49

60.62

*cash/burn updated:

Q3 '20

Company Profile

Driven by innovative science and our entrepreneurial culture, we are focused on the delivery of life-changing medicines that are fuelling growth and contributing value to patients and society.

Drug Pipeline

Click on drug name or indication to see upcoming trial info, prior data, and more general information

Drug | Disease (links)

Stage (next event)

Catalyst Date

AZD1222

COVID-19 Vaccine

Regulatory Submission

2021 (Est)

​

​

Recent Posts

See what the community is saying - click to see full post

AZN - Vaccine hopes rise as Oxford jab prompts immune response among old as well as young adults

AZN - FDA authorizes restart of the COVID-19 AZD1222 vaccine US Phase III trial

AZN - SARS-CoV-2 vaccine, AZD1222, COVID-19 vaccine trials temporary pause

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

​

  • Twitter Social Icon
  • LinkedIn Social Icon